|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 149.1 USD | -1.74% |
|
-4.89% | -1.91% |
| Apr. 12 | Zelman & Associates Downgrades D.R. Horton to Neutral From Outperform | MT |
| Apr. 05 | Citigroup Raises Price Target on D.R. Horton to $191 From $166, Maintains Buy Rating | MT |
D.R. Horton, Inc. updated earnings guidance for fiscal 2022. Consolidated revenues in a range from $35.3 billion to $36.1 billion.
| 1st Jan change | Capi. | |
|---|---|---|
| -1.91% | 49.46B | |
| +5.40% | 22.95B | |
| -0.26% | 18.14B | |
| +9.29% | 14.9B | |
| +14.65% | 12.28B | |
| +9.52% | 6.37B | |
| +10.63% | 6.23B | |
| +4.33% | 5.9B | |
| -2.60% | 6.03B | |
| -8.77% | 5.91B |
DR HORTON 
